The company has demonstrably improved the development of the new therapy for ATTR-CM, employing the compound. Initial clinical data suggests potential improvements for those affected by this serious condition. This emphasis represents the company’s commitment to addressing unmet medical demands in a heart disease space. Attruby: BridgeB… Read More